
Coronavirus News Roundup: Pfizer Releases More Data on COVID-19 Vaccine
Here’s a roundup of the latest coronavirus-related news.
Pfizer and BioNTech announced topline results from an analysis spanning through March 13, which in part showed their COVID-19 vaccine to be 91.3% effective against the virus for up to 6 months after the second dose.
Pfizer/BioNTech has just
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.




















































































































































